Trial intelligence / Profile preview

Efficacy and Safety of GW685698X in Persistent Asthma

NCT00603746Phase 2Completed

Sponsor
GSK
Start
Dec 2007
Primary completion
Sep 2008
Modality
Orthosteric Ligands
Countries
16
01

Overview

A Phase 2 trial of fluticasone in asthma, sponsored by GSK. Started Dec 2007; status: completed.

02

Drugs

fluticasone
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00603746.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00603746.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call